Table 2

Associations of LAG3 methylation and mRNA expression (mean levels) with VHL, PBRM1, SETD2, KDM5C, and BAP1 mutation status in KIRC

Analyte (CpG site/bead, mRNA)Number VHL PBRM1 SETD2 KDM5C BAP1
Wild type (n=179)Mutant
(n=140)
P valueWild type
(n=228)
Mutant
(n=91)
P valueWild type
(n=287)
Mutant
(n=32)
P valueWild type
(n=301)
Mutant
(n=18)
P valueWild type
(n=296)
Mutant
(n=23)
P value
LAG3 mRNANA6.4816.680.36 6.717 6.19 0.028 6.586.420.656.566.650.86 6.51 7.34 0.045
cg26956535188.488.10.7688.388.10.80 89.2 79.7 < 0.001 88.386.80.4188.387.70.72
cg22777668223.822.10.0723.621.70.073 23.4 20.2 0.035 23.3 18.5 0.014 23.023.10.98
cg16352928365.566.00.67 64.4 69.0 0.002 66.063.50.2865.864.30.61 66.3 58.1 0.002
cg02695343465.365.10.91 64.1 68.1 0.007 65.661.60.07965.363.40.52 65.9 57.0 0.001
cg10500147559.359.20.97 57.8 63.0 0.010 60.0 53.2 0.026 59.456.70.48 60.0 50.3 0.006
cg17213699678.377.90.83 76.9 81.1 0.021 78.674.10.09778.375.70.46 78.8 69.0 0.002
cg19872463773.873.80.97 72.6 76.9 0.023 74.369.10.06873.972.10.62 74.4 66.4 0.016
cg04671742878.278.60.67 77.5 80.6 0.006 78.280.10.2678.477.70.7378.775.00.06
cg01820374939.240.20.39 38.6 42.3 0.002 39.838.10.3639.935.70.0839.639.40.91
cg194211251076.176.90.51 75.5 78.9 0.008 76.477.30.6676.674.80.48 77.1 69.3 0.001
cg101910021161.162.20.24 60.8 63.3 0.015 61.661.30.8861.660.90.72 62.0 56.4 0.002
cg206520421276.476.40.95 75.6 78.4 < 0.001 76.377.20.4676.476.80.7976.674.80.19
cg061575701374.776.20.10 74.4 77.8 0.001 75.276.50.40 75.6 70.8 0.015 75.0 79.5 0.012
cg142928701437.636.30.35 38.2 34.1 0.005 37.334.60.2337.333.30.17 36.5 44.0 0.003
cg114292921516.917.90.32 18.1 15.5 0.018 17.515.70.2717.317.50.94 17.0 22.4 0.005
cg15828668165.65.40.315.75.20.135.65.20.465.55.20.625.55.20.53
  • LAG3 methylation was determined at 16 different CpG sites targeted by HumanMethylation450 BeadChip beads (figure 1). Significant data are shown in boldface.

  • KIRC, clear cell renal cell carcinoma; LAG3, lymphocyte activating 3; NA, not applicable.